Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
Introduction Chronic, non-cancer pain impacts approximately 50 million adults in the USA (20%), approximately 25% of whom receive chronic prescription opioids for pain despite limited empirical efficacy data and strong dose-related risk for opioid use disorder and opioid overdose. Also despite lack...
Saved in:
Main Authors: | A Eden Evins, Ellie Grossman, Julia Jashinski, Aurora Quaye, Corinne Cather, Kevin Potter, David A Schoenfeld, Jodi M Gilman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e064457.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prescription of Strong Opioids in Chronic Non-Cancer Pain in the Province of Valladolid (Spain)
by: Rodrigo Enríquez de Salamanca Gambara, et al.
Published: (2025-01-01) -
Opioid Therapy for Chronic Nonmalignant Pain
by: Russell K Portenoy
Published: (1996-01-01) -
Pain catastrophizing is associated with high-dose opioids in patients with cancer pain
by: Simon van Rysewyk, et al.
Published: (2024-12-01) -
Chronic Noncancer Pain and the Long Term Utility of Opioids
by: CPN Watson, et al.
Published: (2004-01-01) -
Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin
by: C Peter N Watson, et al.
Published: (1999-01-01)